VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00274794
Recruitment Status : Completed
First Posted : January 11, 2006
Last Update Posted : March 29, 2011
National Cancer Institute (NCI)
Information provided by:
The Cleveland Clinic